Business Services Industry

aaiPharma Regains Nasdaq Listing Compliance; Ticker Symbol to Revert to AAII on Friday, July 9, 2004

Business Wire, July 8, 2004

WILMINGTON, N.C. -- aaiPharma Inc. (Nasdaq: AAIIE) announced today that it has received notification from Nasdaq that the Company has evidenced compliance with the current requirements necessary for continued listing on The Nasdaq National Market. Effective with the open of business on Friday, July 9, 2004 the Company's ticker symbol will revert to AAII.

About aaiPharma Inc.

aaiPharma Inc. is a science-based pharmaceutical company focused on pain management, with corporate headquarters in Wilmington, North Carolina. With more than 24 years of drug development expertise, the Company is focused on developing, acquiring, and marketing branded medicines in its targeted therapeutic areas. aaiPharma's development efforts are focused on developing improved medicines from established molecules through its significant research and development capabilities. For more information on the Company, including its product development organization AAI Development Services, please visit aaiPharma's website at www.aaipharma.com.

COPYRIGHT 2004 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale